QUEVA CHRISTOPHE (CSO and SVP, Research) sold 23.6% of their position (18.25K shares) of ONCORUS, INC. on the open market
Open‑market sale worth $277.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 4/28/2021ACC: 0001209191-21-028843
Officer· CSO and SVP, Research
Since Oct 2020
-18.25K
Net shares
Net seller
$277.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
18.25K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−54.00
Price / share
$15.00
Trade value
$810.00
% of position
0.1%
4/26/2021
77.43K→77.38K
Common Stock
Direct
Shares
−211.00
Price / share
$15.00
Trade value
$3.17K
% of position
0.3%
4/27/2021
77.38K→77.17K
Common Stock
Direct
Shares
−17.99K
Price / share
$15.22
Trade value
$273.81K
% of position
23.3%
4/28/2021
77.17K→59.17K
Total
Net shares
−18.25K
Net value
-$277.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/26/2021 | S · Sale | −54.00 | $15.00 | $810.00 | 0.1% | 77.43K | 77.38K |
| Common Stock Direct | 4/27/2021 | S · Sale | −211.00 | $15.00 | $3.17K | 0.3% | 77.38K | 77.17K |
| Common Stock Direct | 4/28/2021 | S · Sale | −17.99K | $15.22 | $273.81K | 23.3% | 77.17K | 59.17K |
| Total | −18.25K | -$277.78K | ||||||
Derivative Transactions0
No derivative transactions reported